AsianScientist (Dec. 10, 2014) - Austrianova, a cell-encapsulation company headquartered in Singapore, has officially opened its’ office, lab and good manufacturing practice (GMP) facility at Thailand Science Park, Bangkok.
The opening ceremony included scientific presentations and a site visit of the custom built facility. Attendees included representatives from the Thailand Science Park management, the Thai National Science and Technology Development Agency and the Thailand Center of Excellence for Life Sciences (TCELS) as well as guests of honor Mr. Kenneth L. Waggoner (CEO) and Mr. Gerald C. Crabtree (COO) of Nuvilex Inc., and various other Austrianova partners and friends including the Austrian Trade Commission, Betagro, CDIP, Erber AG, Siricell, Mahidol University, King Mongkut’s University of Technology Thonburi and the team from Austrianova Singapore plus some key investors in Austrianova.
Mr. Brian Salmons, CEO of Austrianova, stated, “Our new facility includes a unique, state-of-the-art and custom-built, controlled environment isolator for cell production, which we believe to be the first in Asia. This isolator system, housed in a newly built conventional Class D cleanroom, will ensure that all Cell-in-a-Box® products are manufactured according to the highest international pharmaceutical production standards.”
Mr. Walter H. Gunzburg, Chairman of Austrianova, said, “We have worked closely with TCELS to develop this world-first encapsulated cell production and research facility. This allows Austrianova to produce Cell-in-a-Box® encapsulated cell products for partners such as Nuvilex, Inc. as well as other key partners. We would like to thank all of our friends for making the opening ceremony such a great success.”
——–
Source: Austrianova.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.